The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Forbes contributors publish independent expert analyses and insights. John Sviokla covers GenAI/AI's impact on commerce and society. This voice experience is generated by AI. Learn more. This voice ...

Before you send something out into the wide world for all of God’s creation to read, it’s important to check it for accuracy. Justin Heap, the Republican election skeptic who keeps bumbling around as ...

Shares of Recursion Pharmaceuticals (RXRX) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials, thanks primarily to a milestone ...

Maricopa County Recorder Justin Heap is in a yearlong dispute with the Board of Supervisors over election administration powers. Heap distanced himself from his chief of staff's sworn testimony that ...

Blue Owl Capital-owned data center company Stack Infrastructure Inc. is seeking a loan of around A$3 billion ($2.1 billion), according to people familiar with the matter, as it accelerates development ...

New York residents who qualify can now apply for the Home Energy Assistance Program. The program is designed for New York residents who are at risk of running out of fuel or having their utility ...

Recursive language models (RLMs) are an inference technique developed by researchers at MIT CSAIL that treat long prompts as an external environment to the model. Instead of forcing the entire prompt ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Dany Lepage discusses the architectural ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...